BRCAA1 Antibody

ARID4B (AT-rich interactive domain-containing protein 4B) is also known as RbBP1L1 (retinoblastoma binding protein 1-like 1) and is a retinoblastoma binding protein and member of the AT-rich interaction domain (ARID) family of proteins. In addition to the ARID DNA binding domain, ARID4B also contains a chromo domain and a TUDOR domain, indicating a function in chromatin organization and protein-protein interactions with methylated protein substrates. As a subunit of the SIN3A transcriptional co-repressor, ARID4B is implicated to be involved in chromatin remodeling and epigenetic modifications. ARID4B may play a role in the pathogenesis of breast cancer and other malignancies.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 3 applications: Chemotaxis, IP, WB.

Showing Publication 1 - 1 of 1.

Publication using NBP1-26618	Applications	Species
Rupaimoole R, Wu Sy, Pradeep S et al. Hypoxia-mediated downregulation of miRnA biogenesis promotes tumour progression Nat Commun et al. 2014-10-29 [PMID: 25351346] (WB, IP, Chemotaxis, Human)	WB, IP, Chemotaxis	Human

Images	Ratings	Applications	Species	Date	Details
	5 reviewed by: rajesha rupaimoole	IP	Human	10/06/2014	View Summary Application Immunoprecipitation Sample Tested Human cancer cell line A2780, MCF7 Species Human

Array NBP1-26618

• BRCAA1 Antibodies
• BRCAA1 Proteins